News

Find News

Filter articles

Showing 2731 to 2740 of 2796 results

Novartis strikes vaccine licensing deal with Indian biopharma

India08-07-2013

Novartis has signed a development and licensing agreement with Indian biopharmaceutical company Biological E Limited (BioE) to deliver two vaccines that protect against typhoid and paratyphoid fevers.

EU court overrules commission in Orphacol drug case

EU05-07-2013

The General Court of the European Union has annulled the European Commission’s decision to refuse marketing authorisation for orphan drug Orphacol.

UCB challenges Teva generic drug application

US03-07-2013

Belgian pharmaceutical company UCB SA has sued drug-maker Teva Pharmaceutical Industries to stop it manufacturing a generic version of epilepsy drug Vimpat.

AbbVie triumphs in Humira case

US02-07-2013Legal developments

Pharmaceutical company AbbVie has won a patent case against UK research body The Kennedy Institute of Rheumatology Trust relating to the arthritis medication Humira.

Merck wins injunction in sitagliptin patent row

India25-06-2013

Pharmaceutical company Merck has secured a preliminary injunction against Indian drug company Aprica after it tried to market generic versions of the branded diabetes drug Januvia.

Generics swoop as Viagra patent expires

EU24-06-2013

Global drug companies Actavis and Teva both launched generic versions of Viagra immediately after its patent expired in several European countries last week.

Federal Circuit holds Novo Nordisk patent invalid

US21-06-2013Legal developments

The US Court of Appeals for the Federal Circuit concluded on June 18 that Novo Nordisk’s patent covering diabetes treatment repaglinide is invalid.

European Commission targets alleged ‘pay-for-delay’ with pharma fines

EU20-06-2013

The European Commission’s competition directorate has levied fines totalling €146 million ($195 million) against originator pharmaceutical company Lundbeck and several producers of generics drugs.

US Supreme Court backs ‘rule-of-reason’ for pay-for-delay

US17-06-2013

A majority of the US Supreme Court has ruled that the US Federal Trade Commission should be able to challenge so-called ‘pay-for-delay’ patent litigation settlements on antitrust grounds.

Teva and Sun stung by $2 billion settlement

US14-06-2013

Generic drug-makers Teva Pharmaceutical and Sun Pharmaceutical have agreed to pay a combined $2.15 billion to settle a patent infringement case over Pfizer’s heartburn drug Protonix.

Showing 2731 to 2740 of 2796 results

LSIPR